Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atherogenesis and hypertension.

L H Block1

  • 1Department of Internal Medicine, Kantonsspital, Basel, Switzerland.

Nephron
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Calcium channel blockers may combat atherosclerosis by improving cholesterol metabolism in blood vessels. These drugs reverse suppressed enzyme activity linked to high blood pressure and arterial disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of constipation with a refined psyllium combined with dextrose.

The American journal of digestive diseases·2010
Same author

Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania.

The European respiratory journal·2009
Same author

Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD.

Thorax·2003
Same author

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.

Thorax·2001
Same author

Differential activation of the STAT pathway by angiotensin II via angiotensin type 1 and type 2 receptors in cultured human fetal mesangial cells.

Experimental and molecular pathology·2001
Same author

The use of chitosan gels as matrices for electrically-modulated drug delivery.

Journal of controlled release : official journal of the Controlled Release Society·2001
Same journal

The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

Nephron·2026
Same journal

Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

Nephron·2026
Same journal

Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

Nephron·2026
Same journal

Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

Nephron·2026
Same journal

Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

Nephron·2026
Same journal

Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

Nephron·2026
See all related articles

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Cell Biology

Background:

  • Low-density lipoprotein (LDL) is crucial for cellular cholesterol balance.
  • Intracellular cholesterol metabolism relies on lysosomal enzymes.
  • Suppressed cholesterol hydrolysis in hypertension contributes to atherosclerosis.

Purpose of the Study:

  • To investigate the link between hypertension, cholesterol metabolism, and atherosclerosis.
  • To explore the antiatherosclerotic effects of calcium antagonists.
  • To examine LDL's role in cellular activation.

Main Methods:

  • Studied hypertensive animal models to assess arterial smooth muscle cholesterol metabolism.
  • Investigated the effect of calcium antagonists on enzyme activity and blood pressure.

Related Experiment Videos

  • Utilized platelets as a model to study LDL-induced cellular activation via phosphatidylinositol turnover.

    • Main Results:

    • Cholesterol hydrolysis was suppressed in the arterial smooth muscle of hypertensive animals.
    • Calcium antagonists reversed this suppressed hydrolytic activity.
    • Calcium antagonists also lowered blood pressure, suggesting a mechanism for their antiatherosclerotic action.
    • Preliminary data indicate LDL induces rapid cellular activation.

    Conclusions:

    • The blood pressure-lowering effect of calcium antagonists may contribute to their antiatherosclerotic properties.
    • Modulating intracellular cholesterol metabolism is a potential therapeutic target for atherosclerosis in hypertension.
    • LDL may play a direct role in cellular activation pathways relevant to vascular disease.